stearates has been researched along with Respiratory-Tract-Infections* in 3 studies
3 other study(ies) available for stearates and Respiratory-Tract-Infections
Article | Year |
---|---|
Clinical and pharmacological evaluation of different preparations of oral erythromycin.
The activity of erythromycin stearate in respiratory tract infections was evaluated. This study involved 269 out-patients. Of these, 76 satisfied the strict criteria for detailed bacteriological study with positive cultures of a known pathogen before treatment and bacteriological follow-up after treatment. The results of erythromycin stearate were good against the haemolytic streptococcal infections. The activity of this antibiotic was shown to be insufficient against Haemophilus influenzae. A second clinical trial with 20 patients with acute exacerbations of chronic bronchitis demonstrated quite good activity from erythromycin ethylsuccinate and no intolerance when administered in a dose of 1 g q.i.d. The administration of 1 g of the ethylsuccinate immediately after a meal gave a peak serum concentration after 60 min of 3.36 micrograms/ml. Blood levels on the fourth day of this treatment showed some accumulation, concentrations of greater than 4 micrograms/ml being found at 30, 60 and 90 min after the dose. With its good absorption, its lack of toxicity and its reputation for good diffusion into bronchial secretions, we consider that erythromycin ethylsuccinate should have a major place in the treatment of respiratory tract infections. Topics: Administration, Oral; Adult; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Follow-Up Studies; Haemophilus influenzae; Humans; Respiratory Tract Infections; Stearates; Succinates | 1979 |
Treatment of acute bacterial infections of the upper respiratory tract.
An open comparative study was carried out to assess the effectiveness of 4 antibiotic regimens in eradicating acute bacterial infections of the upper respiratory tract. Patients in each treatment group had similar physical parameters, severity of disease and bacterial pathogens, and were treated for 10 days with either erythromycin estolate, erythromycin stearate, ampicillin or oxytetracycline in the recommended dosage. Each patient was reviewed daily by physical examination and the bacteriological findings from throat swab and salivary washings. The results showed that erythromycin stearate produced more rapid bacterial eradication and clinical resolution of symptoms and fever than with the other antibiotic preparations, and was well tolerated by most patients. Topics: Acute Disease; Ampicillin; Bacterial Infections; Erythromycin; Erythromycin Estolate; Escherichia coli Infections; Humans; Oxytetracycline; Penicillin Resistance; Respiratory Tract Infections; Stearates | 1977 |
Comparison of erythromycin ethyl succinate, stearate and estolate treatments of group A streptococcal infections of the upper respiratory tract.
The microbiologic and clinical responses of acute Group A beta-hemolytic streptococcal infections of the upper respiratory tract to oral treatment with erythromycin ethyl succinate, stearate, and estolate were studied in 303 patients. Streptococcal M and T typing was done on all positive cultures. The overall cure rate was 95.4 per cent, with no statistically significant differences in clearing organisms from the pharynx. Of the 285 cured patients who completed the prescribed follow-up period, 11 had recurrences between the 12th and 31st day after initiation of therapy, and five developed new infections. No cases of rheumatic fever or glomerulonephritis were encountered during a follow-up study. Eight gastrointestinal reactions and one transient rash occurred. Results with these forms of erythromycin compare favorably with published results for similar infections treated with oral penicillins. Topics: Administration, Oral; Child; Child, Preschool; Erythromycin; Erythromycin Estolate; Female; Follow-Up Studies; Humans; Infant; Male; Penicillins; Recurrence; Respiratory Tract Infections; Stearates; Streptococcal Infections; Streptococcus pyogenes; Succinates | 1975 |